University of Massachusetts Chan Medical School
Welcome,         Profile    Billing    Logout  
 46 Trials 
136 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Scahill, Lawrence
MEASURE-ASD2, NCT05806216: Dynamic Quantification of Social-Visual Engagement in Autism Spectrum Disorder (ASD) For Children Ages 31-84 Months

Recruiting
N/A
790
US
EarliPoint Diagnosis, EarliPoint, Clinically Certain Expert Clinician Diagnosis (CC-ECD), CC-ECD
EarliTec Diagnostics, Inc, Marcus Autism Center
Autism Spectrum Disorder, Autism
03/25
03/25
Grendys, Edward C
GLORIOSA, NCT05445778: Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer

Recruiting
3
418
Europe, Canada, US, RoW
Mirvetuximab soravtansine plus Bevacizumab, MIRV, Bevacizumab
AbbVie, GOG Foundation
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
03/27
04/29
ART_CIN_II, NCT04098744: Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Recruiting
2
78
US
Artesunate vaginal insert, Artesunic acid, DHA, artemisinin, Placebo vaginal insert
Frantz Viral Therapeutics, LLC, Amarex Clinical Research, M.D. Anderson Cancer Center, Harris Health System (L.B.J. Hospital), The Cleveland Clinic, University of Michigan, Morehouse School of Medicine
CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease
07/25
12/25
ART-VIN IIB, NCT06075264: Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

Recruiting
2
27
US
Artesunate ointment, Artesunic acid, Dihydroartemisinin (DHA), Artemisinin, Placebo ointment, Placebo to artesunate ointment
Frantz Viral Therapeutics, LLC, The Cleveland Clinic
Vulvar Diseases, HPV Infection, Vulvar HSIL, Pre-Cancerous Dysplasia, HPV Disease, VIN, Usual Type, VIN 2 of Usual Type, VIN 3 of Usual Type, Vin II, Vin III, VIN Grade 2, VIN Grade 3, High Grade Intraepithelial Neoplasia
12/25
12/26
ACR-368-201, NCT05548296: A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma

Recruiting
1/2
390
US
ACR-368, prexasertib, Gemcitabine, OncoSignature
Acrivon Therapeutics, GOG Foundation
Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma
07/26
12/27
SOROCk, NCT04251052: A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Recruiting
N/A
2262
Canada, US, RoW
Bilateral Salpingectomy, Bilateral Salpingectomy with Oophorectomy, bilateral salpingo-oophorectomy, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Transvaginal Ultrasound, transvaginal sonography, TVS, TVU, Ultrasound Imaging, 2-Dimensional Grayscale Ultrasound Imaging, 2-Dimensional Ultrasound Imaging, 2D-US, Ultrasonography, Ultrasound, Ultrasound Test, Ultrasound, Medical, US
NRG Oncology, National Cancer Institute (NCI)
Ovarian Carcinoma
06/36
06/37
McAlindon, Timothy E
NCT04886258 / 2020-006104-17: Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis

Completed
2
115
Europe, US, RoW
DFV890, Placebo
Novartis Pharmaceuticals, Novartis Pharma AG
Symptomatic Knee Osteoarthritis
12/24
12/24
NCT06201416: Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

Recruiting
1
24
US
SBT777101
Sonoma Biotherapeutics, Inc.
Rheumatoid Arthritis
03/26
03/26
NCT04678999: Mind-body Therapy (Remotely Delivered) for Knee Osteoarthritis

Completed
N/A
50
US
Mind-body exercise and education
Tufts Medical Center
Knee Osteoarthritis
11/22
11/22
RACKTKA, NCT05473663: Radiofrequency Ablation After Total Knee Arthroplasty

Active, not recruiting
N/A
14
US
Radiofrequency Ablation, Sham
University of Massachusetts, Worcester, Boston University, Tufts Medical Center, Rheumatology Research Foundation
Chronic Knee Pain
07/25
09/25
Smith, Christopher P
NCT04318548 / 2016-003722-16: Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

Completed
3
943
Europe, US
Meningococcal Group B Vaccine (GSK3536829A) (rMenB+OMV NZ), Bexsero, Meningococcal MenACWY Conjugate Vaccine (GSK3536820A) (MenA lyo + MenCWY liquid), Menveo, Placebo, NaCl, saline solution
GlaxoSmithKline
Infections, Meningococcal
11/23
11/23
PREPARED-1, NCT06339008: A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis

Recruiting
3
450
Europe, US, RoW
LY3650150, Placebo, Standard therapy for INCS
Eli Lilly and Company
Perennial Allergic Rhinitis (PAR)
10/25
02/27
NIMBLE, NCT04718389 / 2020-003612-28: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Hourglass Feb 2024 - Jun 2024 : Acceptance of regulatory submission in China for CRSwNP
Active, not recruiting
3
1667
Europe, Canada, Japan, US, RoW
GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS)
GlaxoSmithKline, Iqvia Pty Ltd
Asthma
10/25
10/25
NCT05468736: Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Active, not recruiting
2/3
3600
Europe, US, RoW
SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period), NVX-CoV2373, Placebo, Sodium chloride 0.9% (BP, sterile)
Novavax
COVID-19
01/24
10/25
CALM-CSU, NCT06077773: Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria

Recruiting
2
154
Europe, Canada, US
Oral EP262, Placebo
Escient Pharmaceuticals, Inc
Chronic Spontaneous Urticaria
06/25
07/25
NCT06526208: Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults

Not yet recruiting
2
108
US
MB-IMP, MCT oil, Placebo, Medium Chain Triglyceride (MCT) oil
Southwest Autism Research & Resource Center
Autism Spectrum Disorder, Anxiety
09/26
09/27
NCT02839915: Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder

Active, not recruiting
2
56
US
Folinic Acid, Liquid levo-leucovorin, Placebo
Southwest Autism Research & Resource Center, Emory University, Harvard University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), State University of New York - Downstate Medical Center
Autism Spectrum Disorder
04/24
01/25
NCT04060017: Early Treatment of Language Impairment in Young Children with Autism Spectrum Disorder with Leucovorin Calcium

Recruiting
2
80
US
Levoleucovorin Calcium, L-leucovorin, L-leucovorin calcium, L-folinic acid, calcium salt, L-folinate, calcium salt, Placebo
Southwest Autism Research & Resource Center, State University of New York - Downstate Medical Center, United States Department of Defense
Autism Spectrum Disorder, Language Disorders
01/25
01/25
NCT04060030: Treatment of Social and Language Deficits with Leucovorin for Young Children with Autism

Recruiting
2
80
US
Levoleucovorin Calcium, L-leucovorin, L-leucovorin calcium, L-folinic acid, calcium salt, L-folinate, calcium salt, Placebo
Southwest Autism Research & Resource Center, Autism Speaks, State University of New York - Downstate Medical Center
Autism Spectrum Disorder, Language Disorders
01/25
01/25
NCT05081245: ML-004 in Adolescents and Adults with Autism Spectrum Disorders (ASD)

Recruiting
2
150
Canada, US, RoW
ML-004 (IR)/(ER) tablet, ML-004 Placebo
MapLight Therapeutics
Autism Spectrum Disorder
03/25
04/25
NCT01771159: Tissue Bonding Cystostomy(TBC)

Not yet recruiting
1
10
US
TBC
Uro-Research, LLC
Spinal Cord Injury (SCI), Chronic Urinary Retention, Urinary Incontinence
12/20
12/22
NCT05062902: A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management

Not yet recruiting
1
46
US
High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device, Botulinum Neurotoxin
HillMed Inc., Baylor College of Medicine, University of Houston
Interstitial Cystitis, Chronic Pain, Pelvic Floor; Relaxation, Pelvic Floor Disorders
12/27
12/27
HOT, NCT04646798: Hemiarthroplasty Or Total Elbow Arthroplasty in the Elderly.

Not yet recruiting
N/A
20
Europe
Hemiarthroplasty, Total elbow arthroplasty
Royal Devon and Exeter NHS Foundation Trust
Distal Humerus Fracture
05/23
11/23
NCT06334718: Drone Delivered Defibrillators (The 3D Project).

Active, not recruiting
N/A
25
Europe
Interviews and simulation
University of Warwick, Welsh Ambulance Service NHS Trust
Cardiac Arrest, Out-Of-Hospital
10/24
03/25
NCT06354920: M-Well Bonding Bundle to Improve Patient-Physician Relationships

Recruiting
N/A
3624
US
Bonding Bundle
University of Michigan, Agency for Healthcare Research and Quality (AHRQ)
Physician-Patient Relations
06/26
06/26
MEASURE-ASD1, NCT05675371: Treatment Monitoring in Autism Spectrum Disorder (ASD) in Children

Recruiting
N/A
332
US
Assessment by Expert Clinician During Behavioral Intervention (ABA or similar), Applied Behavior Analysis, Assessment by the EarliPoint Assessment For Autism Spectrum Disorder, EarliPoint System: Assessment for Autism Spectrum Disorder
EarliTec Diagnostics, Inc, Marcus Autism Center
Autism Spectrum Disorder, Autism, Developmental Delay, Autism, Early Infantile, Autism, Infantile
09/24
09/24
CHANTS, NCT05870150: Challenge Non-Typhoidal Salmonella () Study

Recruiting
N/A
80
Europe
Salmonella Typhimurium
Imperial College Healthcare NHS Trust, University of Oxford, University of Liverpool, PATH, Imperial College London
Salmonella Infections, Salmonella Typhimurium, Non-typhoidal Salmonella (NTS), Invasive Non-Typhoidal Salmonella Disease, Communicable Disease, Infections, Bacterial, Enteric Fever (Not Typhoid), Gastroenteritis
09/24
06/25
MEASURE-ASD2, NCT05806216: Dynamic Quantification of Social-Visual Engagement in Autism Spectrum Disorder (ASD) For Children Ages 31-84 Months

Recruiting
N/A
790
US
EarliPoint Diagnosis, EarliPoint, Clinically Certain Expert Clinician Diagnosis (CC-ECD), CC-ECD
EarliTec Diagnostics, Inc, Marcus Autism Center
Autism Spectrum Disorder, Autism
03/25
03/25
RECIPE, NCT05685433: A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation

Recruiting
N/A
200
US
eCoin Tibial Nerve Stimulation
Valencia Technologies Corporation
Overactive Bladder, Urge Incontinence, Incontinence, Urinary, Urinary Urge Incontinence
08/25
12/30
NCT04322734: Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Recruiting
N/A
500
US
Southwest Autism Research & Resource Center, State University of New York - Downstate Medical Center
Autism Spectrum Disorder, Mitochondrial Pathology, Epilepsy, Brain Tumor, Psychiatric Disorder, Mitochondrial Diseases
12/28
12/28
Kay, Jonathan
RESET-RA, NCT04539964: Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis

Active, not recruiting
3
243
US
Implant Procedure, Surgical placement of vagus nerve stimulator inside the neck, Conventional Synthetic DMARD, Background therapy with conventional synthetic DMARD, Active stimulation, Non-active stimulation
SetPoint Medical Corporation
Rheumatoid Arthritis
05/24
10/27
TOPAZ-2, NCT04961567 / 2020-005776-35: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Recruiting
3
540
Europe, Canada, Japan, US, RoW
Litifilimab, BIIB059, Placebo
Biogen
Lupus Erythematosus, Systemic
09/25
03/26
RA-PROPR, NCT04692493: RA-PRO PRAGMATIC TRIAL

Recruiting
3
924
Canada, US
targeted synthetic DMARD class, non-TNFi-biologic class
University of Alabama at Birmingham, Patient-Centered Outcomes Research Institute
Rheumatoid Arthritis
02/27
12/28
TANGO, NCT06469788: Testimonials and Navigation in Rheumatology

Recruiting
N/A
1170
US
Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences, Video on the importance of good oral health for patients with AIRD, Attention Control, Brochure on COVID-19 vaccination in AIRD patients, Patient Navigation, Brochure on the importance of good oral health in AIRD patients
University of Alabama at Birmingham, National Institute on Minority Health and Health Disparities (NIMHD), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Rheumatologic Disease, Autoimmune Diseases
04/27
08/27
Muehlschlegel, Susanne
NCT05671874: Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI

Recruiting
N/A
50
US
Web/mobile/tablet-based digital decision aid + communication (DA+C) tool
University of Massachusetts, Worcester, Worcester Polytechnic Institute, National Institutes of Health (NIH), National Institute of Nursing Research (NINR), Johns Hopkins University
Hemorrhagic Stroke, Intracerebral, Acute Ischemic Stroke, Traumatic Brain Injury
06/25
09/25
BOOST3, NCT03754114: Brain Oxygen Optimization in Severe TBI, Phase 3

Recruiting
N/A
1094
Canada, US
ICP + PbtO2 guided management strategy, ICP guided management strategy
University of Michigan, National Institute of Neurological Disorders and Stroke (NINDS), University of Washington, University of Pennsylvania, University of Pittsburgh, Medical University of South Carolina
Brain Injuries, Traumatic
11/27
11/27
Harris, John E
NCT05535738: Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

Recruiting
2/3
45
US
Squaric Acid Dibutyl Ester, Known patch test allergens, Dupilumab, Adalimumab, Ustekinumab, Guselkumab, Canakinumab, Sarilumab, Triamcinolone Acetonide, Betamethasone Valerate, Fluticasone Propionate, Microneedle, Suction blistering, Skin punch biopsy
John Harris
Skin Inflammation, Allergic Contact Dermatitis
01/27
12/27
NCT05607316: Evaluating the Efficacy and Safety of Metformin in Vitiligo

Withdrawn
2
30
US
Metformin Hydrochloride, Glucophage, Glumetza, Riomet
University of Massachusetts, Worcester
Vitiligo
06/28
11/28
Houston, Kevin E
NCT03450980: Mobile Medical Application for Cost-effective Strabismus Screening

Recruiting
N/A
190
US
EyeTurn App
Massachusetts Eye and Ear Infirmary, National Eye Institute (NEI)
Strabismus
12/19
12/22
NCT04678115: Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis

Active, not recruiting
N/A
50
US
Magnetic Levator Prosthesis (MLP), Kinesiotape Frontalis Sling (KTFS)
Massachusetts Eye and Ear Infirmary, National Eye Institute (NEI)
Blepharoptosis, Ptosis, Eyelid, Myasthenia Gravis, Stroke, Traumatic Brain Injury, Chronic Progressive External Ophthalmoplegia
12/24
12/24
NCT03818204: Clinical Trial to Improve the Magnetic Levator Prosthesis

Completed
N/A
17
US
Magnetic Levator Prosthesis (MLP)
Massachusetts Eye and Ear Infirmary
Blepharoptosis, Ptosis, Eyelid, Myasthenia Gravis, Stroke, Traumatic Brain Injury
12/23
12/23
NCT04827147: Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia

Active, not recruiting
N/A
63
US
Multi-Periscopic Prism (MPP) glasses, Fresnel Peripheral Prism (FPP) glasses
Massachusetts Eye and Ear Infirmary, National Eye Institute (NEI)
Homonymous Hemianopia
02/25
02/26
OCNP, NCT06417216: Head-Cancelled Virtual Reality for Ocular Cranial Nerve Palsies

Recruiting
N/A
40
US
Head-cancelled virtual reality
Kevin Houston, American Academy of Optometry
Internuclear Ophthalmoplegia, Palsy, Abducens
06/26
06/26
Zweizig, Susan
FLORA-4, NCT04498117 / 2020-002270-26: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Active, not recruiting
3
615
Europe, Canada, US, RoW
Oregovomab, MAb-B43.13, Paclitaxel, Taxol, Carboplatin, Paraplatin, Placebo
CanariaBio Inc., Gynecologic Oncology Group, Iqvia Pty Ltd
Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Peritoneal Cancer, Peritoneal Carcinoma, Peritoneal Neoplasms
09/25
08/27
NRG-GY019, NCT04095364: Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recruiting
3
450
Europe, Canada, US, RoW
Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Imaging Technique, Diagnostic Imaging Technique, Image Type, Imaging, Imaging (procedure), imaging procedure, Imaging Procedures, imaging type, IMAGING_METHOD, imaging_type, Medical Imaging, Type of imaging, Letrozole, CGS 20267, Femara, Fempro, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat
NRG Oncology, National Cancer Institute (NCI)
Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8, Stage III Fallopian Tube Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Primary Peritoneal Cancer AJCC v8, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8
02/27
02/28
REFRaME-O1, NCT05870748: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1

Recruiting
2/3
600
Canada, US, RoW
Luveltamab tazevibulin, STRO-002, Luvelta, Pegfilgrastim, Neulasta, Gemcitabine, Paclitaxel, Pegylated liposomal doxorubicin, Topotecan
Sutro Biopharma, Inc., GOG Foundation, European Network of Gynaecological Oncological Trial Groups (ENGOT), Asia-Pacific Gynecologic Oncology Trials Group (APGOT)
Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Platinum-resistant Ovarian Cancer
08/27
02/28
PROFECTA-II, NCT04374630: Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian

Completed
2
150
US, RoW
Paclitaxel, Afuresertib, LAE002
Laekna Limited
Platinum-resistant Ovarian Cancer
07/23
06/24
NCT03835819: A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)

Active, not recruiting
2
18
US
Pembrolizumab, Keytruda, IMGN853, Mirvetuximab soravtansine, Elahere
Dana-Farber Cancer Institute, ImmunoGen, Inc., Merck Sharp & Dohme LLC
Endometrial Cancer
06/24
05/27
GOG-3039, NCT04393285: Abemaciclib and Letrozole to Treat Endometrial Cancer

Active, not recruiting
2
53
US
Abemaciclib, Letrozole
Gynecologic Oncology Group, Eli Lilly and Company
Endometrial Cancer
12/24
12/25
NCI-2017-01672, NCT03660826: Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Active, not recruiting
2
286
Canada, US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspirate, BONE MARROW, LIQUID, Human Bone Marrow Aspirate, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Capivasertib, AZD 5363, AZD-5363, AZD5363, Truqap, Cediranib, AZ-D2171, AZD 2171, AZD2171, Cediranib Maleate, AZD2171 Maleate, Recentin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Durvalumab, Imfinzi, Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer, MEDI 4736, MEDI-4736, MEDI4736, Echocardiography, EC, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNV Scan, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Olaparib, AZD 2281, AZD-2281, AZD2281, KU 0059436, KU-0059436, KU0059436, Lynparza, Olanib, Olaparix, PARP Inhibitor AZD2281
National Cancer Institute (NCI), NRG Oncology
Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Endometrioid Adenocarcinoma, Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
12/24
01/26
NCT06388018: Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer

Recruiting
2
325
US
Clinical Observation, observation, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, External Beam Radiation Therapy, Definitive Radiation Therapy, EBRT, External Beam Radiation, External Beam Radiotherapy, External Beam Radiotherapy (conventional), External Beam RT, external radiation, External Radiation Therapy, external-beam radiation, Radiation, External Beam, Teleradiotherapy, Teletherapy, Teletherapy Radiation, High-Dose-Rate Vaginal Brachytherapy, HDR-IVB, High-Dose-Rate Intra-Vaginal Brachytherapy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Questionnaire Administration, X-Ray Imaging, Conventional X-Ray, Diagnostic Radiology, Medical Imaging, X-Ray, Plain film radiographs, Radiographic Imaging, Radiographic imaging procedure (procedure), Radiography, RG, Static X-Ray, X-Ray
NRG Oncology, National Cancer Institute (NCI)
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8, Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8, Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
01/27
01/27
GOG-3088, NCT05649956: Letrozole in Uterine Leiomyosarcoma

Recruiting
2
40
US
Letrozole
GOG Foundation
Uterine Leiomyosarcoma
07/28
07/29
CCTG EN10, NCT05640999: Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Recruiting
2
325
Europe, Canada, US, RoW
Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation
Canadian Cancer Trials Group, Canadian Cancer Clinical Trials Network
Endometrial Cancer
12/28
06/29
ACR-368-201, NCT05548296: A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma

Recruiting
1/2
390
US
ACR-368, prexasertib, Gemcitabine, OncoSignature
Acrivon Therapeutics, GOG Foundation
Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma
07/26
12/27
Frazier, Jean
NCT05358886: A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

Recruiting
3
150
US
BPN14770/ zatolmilast, Placebo
Tetra Discovery Partners
Fragile X Syndrome
06/25
09/25
NCT01908192 / 2017-001168-39: Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

Terminated
2/3
60
US, RoW
NaBen®, Placebo
SyneuRx International (Taiwan) Corp
Schizophrenia
10/23
10/23
NCT05163808: A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome

Recruiting
2/3
150
US
zatolmilast, BPN14770, Placebo
Tetra Discovery Partners
Fragile X Syndrome
09/25
12/25
NCT05418023: Validation of a Salivary miRNA Diagnostic Test for ASD

Recruiting
N/A
6604
US
Salivary Collection, Adaptive Assessment, Medical and Demographic questionnaire, Autism Assessment, Intellectual Development Assessment
Quadrant Biosciences Inc., University of California, Irvine, Holland Bloorview Kids Rehabilitation Hospital, Children's Hospital of Philadelphia, MetroHealth Medical Center, University of Rochester, Nationwide Children's Hospital, Children's Hospital Medical Center, Cincinnati, University of Pittsburgh, University of Massachusetts, Worcester, Children's Hospital Los Angeles, Prisma Health-Upstate, University of Virginia, State University of New York - Upstate Medical University, Rush University, Seattle Children's Hospital, Drexel University, Emory University
Autism Spectrum Disorder, Developmental Delay
07/23
07/23
Hartigan, Celia
NCT05535738: Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

Recruiting
2/3
45
US
Squaric Acid Dibutyl Ester, Known patch test allergens, Dupilumab, Adalimumab, Ustekinumab, Guselkumab, Canakinumab, Sarilumab, Triamcinolone Acetonide, Betamethasone Valerate, Fluticasone Propionate, Microneedle, Suction blistering, Skin punch biopsy
John Harris
Skin Inflammation, Allergic Contact Dermatitis
01/27
12/27
REVEAL, NCT04338581: Evaluation of AMG 714 for Vitiligo

Active, not recruiting
2
57
US
AMG 714, Placebo, nbUVB phototherapy, narrow band ultraviolet B phototherapy
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN), PPD DEVELOPMENT, LP, Rho Federal Systems Division, Inc., Amgen
Vitiligo
10/24
04/25
NCT05529134: Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene

Not yet recruiting
1/2
8
US
PTW-002 10 mg/g gel, Placebo
Phoenicis Therapeutics
Dystrophic Epidermolysis Bullosa
04/24
07/24
TONE, NCT05971381: Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Completed
N/A
109
US
RECELL® Autologous Cell Harvesting Device, Spray-On SkinTM Cells
Avita Medical
Vitiligo
07/24
01/25
NCT05403710: Botulinum Toxin Therapy in Hidradenitis Suppurativa

Recruiting
N/A
20
US
Botulinum toxin, Botox
University of Massachusetts, Worcester, Hidradenitis Suppurativa Foundation, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Hidradenitis Suppurativa, Hyperhidrosis
04/28
04/28
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting
N/A
15000
Europe, Canada, US
Target PharmaSolutions, Inc.
Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria
12/50
12/50
Cachia, David
NCT05488873: A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy

Active, not recruiting
2
60
US
WST-057 Active, Active, Placebo
WinSanTor, Inc
Chemotherapy-induced Peripheral Neuropathy
04/26
05/26
NCT04762069 / 2021-003659-40: A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

Hourglass Jan 2023 - Jun 2023 : Data from trial for glioblastoma
Hourglass Jul 2022 - Dec 2022 : Interim analysis data from trial for glioblastoma in adults
Active, not recruiting
2
210
Europe, US
Berubicin, Berubicin Hydrochloride, Lomustine, Lomustine Capsules, CCNU, CeeNU, Gleostine
CNS Pharmaceuticals, Inc., Worldwide Clinical Trials
Glioblastoma Multiforme, Adult
12/24
03/25
A071401, NCT02523014: Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients with Progressive Meningiomas

Recruiting
2
124
US
Vismodegib, GDC-0449, FAK Inhibitor GSK2256098, Capivasertib, AZD5363, Abemaciclib
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), GlaxoSmithKline, Genentech, Inc., Brain Science Foundation
Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation
01/26
01/28
NCT03994796: Genetic Testing in Guiding Treatment for Patients with Brain Metastases

Recruiting
2
186
US
Abemaciclib, PI3K Inhibitor paxalisib, Entrectinib, Adagrasib, MRTX849
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), Mirati Therapeutics Inc., Genentech, Inc., Eli Lilly and Company, Kazia Therapeutics Limited
CDK Gene Mutation, Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm, NTRK Family Gene Mutation, PI3K Gene Mutation, ROS1 Gene Mutation, KRAS G12C Mutation
10/26
06/28
NRG-BN010, NCT04729959: Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

Active, not recruiting
2
53
US
Atezolizumab, MPDL 3280A, MPDL 328OA, MPDL-3280A, MPDL3280A, MPDL328OA, RG 7446, RG-7446, RG7446, RO 5541267, RO-5541267, RO5541267, Tecentriq, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Conventional Surgery, Fractionated Stereotactic Radiation Therapy, Fractionated Stereotactic Radiotherapy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Tocilizumab, Actemra, IL-6 receptor monoclonal antibodies: tocilizumab, Immunoglobulin G1, Anti-(Human Interleukin 6 Receptor) (Human-Mouse Monoclonal MRA Heavy Chain), Disulfide with Human-Mouse Monoclonal MRA Kappa-Chain, Dimer, MRA, R-1569, RoActemra
National Cancer Institute (NCI), NRG Oncology
Diffuse Astrocytoma, IDH-Wildtype, Recurrent Glioblastoma
08/25
08/25
TRIDENT, NCT04471844: Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant with RT & TMZ for the Treatment of Newly Diagnosed GBM

Active, not recruiting
N/A
982
Europe, Canada, Japan, US, RoW
Optune®
NovoCure Ltd.
Glioblastoma Multiforme
01/26
01/26
Danila, Maria I
ReAKTIV, NCT06488144: Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans

Not yet recruiting
3
254
US
Health coach, Remote Incentive Program
VA Office of Research and Development
Osteoarthritis, Knee
03/29
06/29
NCT03842995: South-seq: Deoxyribonucleic Acid (DNA) Sequencing for Newborn Nurseries in the South

Completed
N/A
477
US
Genetic Counselor, Trained Healthcare Provider
University of Alabama at Birmingham, University of Mississippi Medical Center, HudsonAlpha Institute for Biotechnology, Woman's Hospital, Louisiana, Children's Hospital of New Orleans, Norton's Children's Hospital, University of Louisville
Whole Genome Sequencing
05/22
12/23
NCT04704544: Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE)

Active, not recruiting
N/A
652
US
Tele-rheumatology
University of Alabama at Birmingham, University of California, San Francisco, Tulane University, Rheumatology Research Foundation
Rheumatic Diseases
11/23
12/25
RESTORE, NCT06455085: REducing Future FractureS and Improving OuTcOmes of FRagility FracturE

Recruiting
N/A
2634
US
Augmented-Fracture Liaison Service Arm, Enhanced Usual Care Arm
University of Alabama at Birmingham, Patient-Centered Outcomes Research Institute
Osteoporosis, Osteoporotic Fractures
06/29
06/29
TANGO, NCT06469788: Testimonials and Navigation in Rheumatology

Recruiting
N/A
1170
US
Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences, Video on the importance of good oral health for patients with AIRD, Attention Control, Brochure on COVID-19 vaccination in AIRD patients, Patient Navigation, Brochure on the importance of good oral health in AIRD patients
University of Alabama at Birmingham, National Institute on Minority Health and Health Disparities (NIMHD), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Rheumatologic Disease, Autoimmune Diseases
04/27
08/27
Figueira, Sarah
EXPLORE44, NCT05670730: Study of AOC 1044 in Healthy Adult Volunteers and Participants with Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping

Active, not recruiting
1/2
64
US
AOC 1044, Placebo, Saline
Avidity Biosciences, Inc.
Duchenne Muscular Dystrophy, Exon 44
01/25
01/25
Torres, Esther A
NCT05443490: Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in Children

Recruiting
N/A
150
Europe
Probiotic mixture with three bacterial strains with maltodextrin as a carrier., Placebo comparator with maltodextrin as a carrier.
Bionou Research, S.L., Biopolis S.L.
Atopic Dermatitis
12/24
03/25
DAIN, NCT05627128: A Culturally Tailored Dietary Intervention to Treat Crohn's Disease

Recruiting
N/A
150
US
DAIN
University of Massachusetts, Worcester, University of Puerto Rico, The Leona M. and Harry B. Helmsley Charitable Trust
Crohn Disease
07/25
10/25
Maldonado-Contreras, Ana
NCT03850600: Modulating Early Life Microbiome Through Dietary Intervention in Crohn's Disease

Active, not recruiting
N/A
194
US
Diet-CD, Diet Arm
Icahn School of Medicine at Mount Sinai, The Leona M. and Harry B. Helmsley Charitable Trust, University of Massachusetts, Worcester
Crohn Disease, Pregnancy
11/27
11/27
DAIN, NCT05627128: A Culturally Tailored Dietary Intervention to Treat Crohn's Disease

Recruiting
N/A
150
US
DAIN
University of Massachusetts, Worcester, University of Puerto Rico, The Leona M. and Harry B. Helmsley Charitable Trust
Crohn Disease
07/25
10/25
palma, Ingrid
CBX-12-101, NCT04902872: Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Active, not recruiting
1/2
130
US
CBX-12
Cybrexa Therapeutics
Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma, Breast Cancer, Colorectal Cancer, Pancreas Cancer, Appendix Cancer, Non-small Cell Lung Cancer, Gastric Cancer, Esophagus Cancer, Urothelial Carcinoma, Sarcoma
01/25
03/25
KEYNOTE-B47, NCT04130516: Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and with Pembrolizumab

Recruiting
1/2
200
US
LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER, Pembrolizumab - anti-PD-1 antibody, KEYTRUDA®, Pembrolizumab
Linnaeus Therapeutics, Inc., Merck Sharp & Dohme LLC
Solid Tumor, Adult
12/26
12/27
NCT04875806: A Safety and Tolerability Study of NC762 in Subjects with Advanced or Metastatic Solid Tumors

Terminated
1/2
40
US
NC762
NextCure, Inc.
Advanced or Metastatic Solid Tumors, Ovarian Cancer, Non-small Cell Lung Cancer, Breast Cancer
01/24
01/24
ABOYA-119, NCT04905914: Study of ATRN-119 in Patients with Advanced Solid Tumors

Recruiting
1/2
132
US
ATRN-119
Aprea Therapeutics
Advanced Solid Tumor
12/24
06/25
NCT05902988: A Phase I/II Study of VLS-1488 in Subjects with Advanced Cancer

Recruiting
1/2
120
US
VLS-1488
Volastra Therapeutics, Inc.
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer, Triple Negative Breast Cancer, Gastric Adenocarcinoma, Colorectal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Transitional Cell Carcinoma of Bladder, Head and Neck Squamous Cell Carcinoma, Ovarian Carcinosarcoma, Uterine Carcinosarcoma, Uterine Serous Carcinoma, Endometrium Cancer, Chromosomal Instability
12/25
06/26
ACR-368-201, NCT05548296: A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma

Recruiting
1/2
390
US
ACR-368, prexasertib, Gemcitabine, OncoSignature
Acrivon Therapeutics, GOG Foundation
Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma
07/26
12/27
NCT04717375: Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors

Recruiting
1/2
456
Europe, Canada, US, RoW
SAR444881, BND-22, Pembrolizumab, Cetuximab, Carboplatin, Pemetrexed
Sanofi
Cancer, Neoplasm
02/27
02/27
NCT04237649: KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors

Terminated
1
77
Europe, Canada, Japan, US, RoW
KAZ954, PDR001, NIR178, NZV930
Novartis Pharmaceuticals
Solid Tumors
09/23
09/23
QTX3034-001, NCT06227377: QTX3034 in Patients With KRAS G12D Mutation

Recruiting
1
250
US
QTX3034, Cetuximab
Quanta Therapeutics
Solid Tumors
04/27
04/27
NCT05082610: A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors

Recruiting
1
313
US
HMBD-002, Pembrolizumab
Hummingbird Bioscience, Merck Sharp & Dohme LLC
Cancer, Tumor, Solid, Nonsmall Cell Lung Cancer, Triple Negative Breast Cancer, Malignant Neoplasm, Metastatic Cancer, Advanced Solid Tumor
03/25
07/25
CPO-100-US-101, NCT04931823: Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors

Active, not recruiting
1
126
US
CPO-100, DTX-HSA
Conjupro Biotherapeutics, Inc., CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Solid Tumor
03/25
03/25
KEYNOTE-F86, NCT05787587: A Study of PARG Inhibitor IDE161 in Participants with Advanced Solid Tumors

Recruiting
1
216
US
IDE-161, Pembrolizumab, KEYTRUDA®
IDEAYA Biosciences, Merck Sharp & Dohme LLC
Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer, Pancreas Cancer, Prostate Cancer, Endometrial Cancer, Colorectal Cancer, Head and Neck Cancers
10/26
05/27
NCT05702424: Evaluation of IGM-7354 in Adults With Relapsed and/or Refractory Cancer

Completed
1
14
US
IGM-7354
IGM Biosciences, Inc.
Solid Tumor
05/24
05/24
NCT05753722: A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

Recruiting
1
270
US
PRTH-101, Pembrolizumab
Incendia Therapeutics
Advanced or Metastatic Solid Tumors
09/27
09/27
ELVCAP-002-01, NCT05980416: Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

Recruiting
1
120
Japan, US, RoW
EO-3021
Elevation Oncology
Pancreas Neoplasm, Stomach Neoplasm, Gastrointestinal Neoplasms, Digestive System Neoplasm, Neoplasms by Site, Neoplasms
09/28
12/28
Pepka-Jones, Dawn
NCT03835819: A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)

Active, not recruiting
2
18
US
Pembrolizumab, Keytruda, IMGN853, Mirvetuximab soravtansine, Elahere
Dana-Farber Cancer Institute, ImmunoGen, Inc., Merck Sharp & Dohme LLC
Endometrial Cancer
06/24
05/27
NCT05488873: A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy

Active, not recruiting
2
60
US
WST-057 Active, Active, Placebo
WinSanTor, Inc
Chemotherapy-induced Peripheral Neuropathy
04/26
05/26
ACR-368-201, NCT05548296: A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma

Recruiting
1/2
390
US
ACR-368, prexasertib, Gemcitabine, OncoSignature
Acrivon Therapeutics, GOG Foundation
Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma
07/26
12/27
Brubaker, Lindsay
HOTT, NCT05659381: Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Recruiting
3
230
US
Cisplatin, Platinol AQ, No treatment
GOG Foundation, GlaxoSmithKline
Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer, Stage IV Primary Peritoneal Cancer, Stage III Fallopian Tube Cancer, Stage IV Fallopian Tube Cancer
08/29
08/34
NRG-GY029, NCT05295589: Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy

Withdrawn
2
96
US
Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Copanlisib Hydrochloride, 5-Pyrimidinecarboxamide, 2-Amino-N-(2,3-dihydro-7-methoxy-8-(3-(4-morpholinyl)propoxy)imidazo(1,2-C)quinazolin-5-yl)-, Hydrochloride (1:2), Aliqopa, BAY 80-6946 Dihydrochloride, BAY-80-6946 Dihydrochloride, Copanlisib Dihydrochloride, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, Olaparib, AZD 2281, AZD-2281, AZD2281, KU-0059436, Lynparza, PARP Inhibitor AZD2281, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Pegylated Liposomal Doxorubicin Hydrochloride, ATI-0918, Caelyx, Dox-SL, Doxil, Doxilen, Doxorubicin HCl Liposomal, Doxorubicin HCl Liposome, Doxorubicin Hydrochloride Liposome, Duomeisu, Evacet, LipoDox, Lipodox 50, Liposomal Adriamycin, Liposomal Doxorubicin Hydrochloride, Liposomal-Encapsulated Doxorubicin, Pegylated Doxorubicin HCl Liposome, S-Liposomal Doxorubicin, Stealth Liposomal Doxorubicin, TLC D-99, Topotecan Hydrochloride, Hycamptamine, Hycamtin, SKF S-104864-A, Topotecan HCl, topotecan hydrochloride (oral)
National Cancer Institute (NCI), NRG Oncology
Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Fallopian Tube High Grade Serous Adenocarcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma, Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Resistant Fallopian Tube Carcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma, Recurrent Platinum-Resistant Primary Peritoneal Carcinoma, Recurrent Primary Peritoneal Endometrioid Adenocarcinoma, Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma
03/23
03/23
 

Download Options